Nmible
Clinical trial reimbursement and payment infrastructure for sponsors, CROs, sites and clinical research platforms
Highlights
- New on EvolcAdded 2026-11-05
About Nmible
Nmible provides payment infrastructure for clinical trial reimbursements, including participant payouts, in-clinic reimbursements, approvals and reporting. Its offerings include managed payment services, white-labelled SaaS, embedded integrations and combined reimbursement and travel workflows.
Customers include trial sponsors, CROs, research sites and technology partners such as ePRO and EDC providers. The company offers managed services and software and payment capabilities for use in clients’ own platforms.
NMIBLE LTD was founded in 2019 and is headquartered in London. The platform supports global and localized payout options.
Product: Clinical trial reimbursement infrastructure with managed payments, white-labelled software, embedded payment integrations and participant payout workflows.
Jobs at Nmible
More fintech companies
Noble Grossart
Merchant bank providing corporate finance advice and long-term investment for UK companies and institutionsNew on EvolcNochex
Online and telephone payment processing for UK businesses, charities and online merchantsNew on EvolcNokkel Technologies
Property wealth data and planning tools for UK financial advisers and their homeowner clientsNew on EvolcNorfolk Capital Group
Investment group backing UK financial services companies serving consumers and SMEsNew on EvolcNorthern Gritstone
Invests in and supports early-stage science and technology startups in the North of EnglandNew on EvolcNorthstar Ventures
Venture capital investor backing early and later stage climate tech and healthy ageing companies, based in the North East of EnglandNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-amz-cf-id
- Response headerx-amz-cf-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.